nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death
|
Woosley, Raymond L. |
|
2017 |
40 |
6 |
p. 465-474 |
artikel |
2 |
A Survey on Pharmacovigilance Activities in ASEAN and Selected Non-ASEAN Countries, and the Use of Quantitative Signal Detection Algorithms
|
Chan, Cheng Leng |
|
2017 |
40 |
6 |
p. 517-530 |
artikel |
3 |
Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice
|
Poluzzi, Elisabetta |
|
2017 |
40 |
6 |
p. 461-464 |
artikel |
4 |
Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals
|
Schick, Andreas |
|
2017 |
40 |
6 |
p. 497-503 |
artikel |
5 |
Evaluation of ‘SAEFVIC’, A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia
|
Clothier, Hazel J. |
|
2017 |
40 |
6 |
p. 483-495 |
artikel |
6 |
Medicines Save, Medicines Kill
|
Lexchin, Joel |
|
2017 |
40 |
6 |
p. 457-459 |
artikel |
7 |
Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative Study
|
Kesselheim, Aaron S. |
|
2017 |
40 |
6 |
p. 531-542 |
artikel |
8 |
Pharmacovigilance of Regenerative Medicine Under the Amended Pharmaceutical Affairs Act in Japan
|
Inokuma, Yasuko |
|
2017 |
40 |
6 |
p. 475-482 |
artikel |
9 |
The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone–Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case–Control Study
|
Jobski, Kathrin |
|
2017 |
40 |
6 |
p. 505-515 |
artikel |